The Established and Evolving Role of Nailfold Capillaroscopy in Connective-Tissue Disease by Parker, Matthew J.S. & McGill, Neil W.
Selection of our books indexed in the Book Citation Index 
in Web of Science™ Core Collection (BKCI)
Interested in publishing with us? 
Contact book.department@intechopen.com
Numbers displayed above are based on latest data collected. 
For more information visit www.intechopen.com
Open access books available
Countries delivered to Contributors from top 500 universities
International  authors and editors
Our authors are among the
most cited scientists
Downloads
We are IntechOpen,
the world’s leading publisher of
Open Access books
Built by scientists, for scientists
12.2%
122,000 135M
TOP 1%154
4,800
1Chapter
The Established and Evolving 
Role of Nailfold Capillaroscopy in 
Connective-Tissue Disease
Matthew J.S. Parker and Neil W. McGill
Abstract
Nailfold capillaroscopy (NFC) is a low-cost, non-invasive, rapid, highly specific 
and reproducible investigation well established in the diagnosis of systemic sclerosis 
and related conditions. This chapter will detail the relevant underlying scientific 
principles that underpin the investigation, the methods for performing NFC, the 
range of abnormalities that can be present and the currently available classifica-
tion criteria before moving on to discuss the various established and emerging 
applications as relevant to the connective tissue diseases. In addition to its role in the 
diagnosis of SSc, highlighted by its inclusion in the most recent ACR/EULAR con-
sensus classification criteria, NFC has been shown to predict disease activity, many 
organ-specific complications such as digital ulcers, pulmonary hypertension and 
interstitial lung disease, and even mortality. It is emerging as a useful investigation 
in other CTDs characterised by microvasculopathy, such as in the idiopathic inflam-
matory myopathies and mixed connective tissue disease, as well as being studied 
as a serial investigation in patients to act as a potential biomarker and measure of 
treatment efficacy. NFC can contribute to the earlier identification of patients with 
CTDs with clinically important complications and if applied accurately, therefore, 
can help improve outcomes in these often challenging diseases.
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1. Introduction
The technique of nailfold capillaroscopy (NFC) was first described almost 
100 years ago by Brown and O’Leary, but its utility in connective tissue disease 
was first truly recognised and demonstrated through the work of Maricq et al. 
in the 1970s and 1980s [1–3]. It is now established as a low-cost, non-invasive, 
highly specific, reproducible, and rapid investigation in the diagnostic workup of 
scleroderma-spectrum disorders and, tellingly, was included in the most recent 
ACR/EULAR systemic sclerosis classification criteria [4]. As a consequence, 
there has never been more interest in capillaroscopy and contemporary research 
is actively evaluating both the additional utility of NFC within scleroderma-
spectrum disorders as well as in other diseases characterised by microvascu-
lopathy. This chapter will summarise the techniques and principles of NFC, 
its established role, and explore the emerging roles for NFC with a focus on 
connective-tissue diseases.
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2. What is nailfold capillaroscopy?
As the name implies, NFC involves visualising the nailfold capillaries. Capillaries 
are the smallest blood vessels, with a size that normally allows the passage of a single 
red blood cell at a time. They form a complex network of “loops” (U-shaped structures 
commonly compared to hairpins) with an afferent (arterial) and efferent (venous) 
limb and an apex connecting the two (see Figure 1). These small vessels aid the diffu-
sion of gases and the movement of substrates for and non-essential by-products of cel-
lular respiration. The skin has a rich network of capillaries which are usually orientated 
vertically, distributing blood from the deep cutaneous arterioles to the surface skin and 
then back down again to the venous plexus. In contrast, at the nailfolds, these capillary 
loops lie horizontally which allows a visualisation along the length of their course. To 
be strictly accurate, we are not able to visualise the capillaries themselves, the thin walls 
of which are essentially transparent, but instead the column of red blood cells. Over 
many years researchers have identified abnormalities in the structure and arrangement 
of these capillaries present in certain diseases characterised by microvasculopathy. 
These abnormalities are discussed in more detail later.
3. Nailfold capillaroscopy techniques
NFC consists of two interrelated elements, image acquisition and image inter-
pretation, and these will be discussed in turn in this and the following sections.
3.1 General principles
For all techniques, there are a number of general principles that should be 
observed. Firstly, to minimise the potential for variability in findings due to vaso-
constriction and altered digital perfusion, capillaroscopy should be performed in a 
warm environment, with most studies suggesting a 15–30 minute period of accli-
matisation to “room temperature”, usually around 20°C. Subjects should be advised 
to avoid smoking, caffeine or medications (where possible) that could cause periph-
eral vasoconstriction immediately prior to the investigation. Secondly, visualisation 
of the nailfold capillaries is aided by the use of a gel or oil interface to reduce surface 
reflection from the device light source. The more commonly used substances are 
clear or lightly coloured oils (such as paraffin or light olive oil) or lubricant jellies, 
applied in the region of the nailbed and cuticle immediately prior to visualisation. 
There are an increasing number of differing techniques for acquiring images and we 
will discuss the most frequently employed.
Figure 1. 
Normal nailfold capillaries. The typical appearance of capillary “loops”.
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3.2 Widefield stereomicroscopy
Widefield stereomicroscopy (WSM; see Figure 2a) is the original technique 
pioneered by Maricq et al. and is still considered one of the two “gold-standard” 
techniques [2, 3, 5]. Each nailfold (usually of just the index-little finger of each 
hand, as thumbs can be difficult to orientate under the microscope) is examined at 
around 20-fold magnification which allows for a panoramic view of the entire nail-
fold. The microscope allows close control of depth of focus. The microscope can be 
combined with a camera and other digital equipment to allow recording of images 
and assist real-time explanation of investigation findings. The technique typically 
takes around 5 minutes to complete.
3.3 High-magnification videocapillaroscopy
Nailfold videocapillaroscopy (NVC; see Figure 2b) is the other “gold-standard” 
technique and is now the most frequent technique used in capillaroscopy research. 
Either a fixed or handheld imaging device is used which, when combined with 
computer software, affords a highly magnified view of the nailfold at 200–300-fold. 
This technique allows for very detailed images but an important consequence is 
that not all the nailfold can be visualised at the same time. The impact of this can be 
particularly relevant to studies looking at longitudinal nailfold changes (see later), 
as it can be difficult at subsequent study visits to visualise the exact same region of 
the nailfold. There is software that can ‘stitch’ together images using digital picture 
recognition and therefore produce a panoramic nailfold image made up of smaller 
high magnification images, first used by Herrick et al., which can mitigate this 
issue [6]. NVC can take substantially longer than other techniques if all fingers are 
studied (20–30 minutes), and consequently many studies restrict image acquisition 
to a single finger in both hands (most commonly the ring finger). An important 
potential downside of this compromise is that nailfold changes can vary markedly 
between even adjacent fingers. NVC has been shown in multiple studies to have 
good intra- and inter-observer variability and/or concordance and correlates well 
with WSM [6–9].
3.4 Handheld devices—ophthalmoscopes, dermatoscopes, USB microscopes etc.
Two important factors that have limited accessibility to NFC and its use in the 
broader rheumatology community are the relative (expensive) cost and the lack 
of portability of the two gold-standard techniques. There are clear advantages to 
being able to take a test to the “bedside” rather than having to bring a patient to the 
test, which is often only currently available at a small number of specialist institu-
tions. Fortuitously, there are a number of low cost and handheld devices such as 
dermatoscopes and ophthalmoscopes which achieve a good visualisation of the 
nailfolds at around 10–20-fold magnification (see Figure 2c). A number of studies 
directly comparing these techniques with WSM and NVC have found a reassuring 
concordance [10–12]. In particular, although the rate of “unclassifiable” images 
is higher, ample diagnostically relevant findings can be elicited, even if more 
subtle changes can be missed. Rapidly improving technology, particularly with 
the availability of USB microscopes or attachments for smartphones, can already 
achieve similar magnification to NVC and record images. This infers that these 
devices are going to become more commonplace [11]. An additional advantage 
with the handheld devices is that they can be easier to use in patients with finger 
deformities and in thumbs (or even toes) which are often not visualised in other 
techniques, although the additional information gleaned from these is not yet of 
clear clinical utility.
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4. Nailfold capillary abnormalities
Before proceeding to discuss nailfold capillary abnormalities, it is important to 
note that there is a surprisingly broad range of capillary appearances between or 
even within ‘normal’ subjects and the disease controls used in research settings [13]. 
It can sometimes be difficult to be certain whether subtle changes are of signifi-
cance or not but with increasing experience this distinction becomes somewhat 
easier. In practice, most examinations will clearly fall into a normal or definitely 
abnormal category and for those that do not there is usually extra information from 
a history, examination and additional diagnostic tests that can help contextualise 
the capillaroscopy results.
The abnormal features that originally defined Maricq’s “scleroderma-dermato-
myositis pattern (SD-pattern) remain the most important to examine for [2]. These 
consist of giant (significantly enlarged) capillaries, avascular areas (also referred 
to as capillary “drop-out”), and microhaemorrhages. Other abnormalities are 
recognised and include excessively tortuous capillaries, unusually shaped capillaries 
(“bushy” or “arborized” capillaries) and cuticular hypertrophy, but their clinical 
significance especially in isolation is less well established.
4.1 Giant capillaries
There is no universally agreed definition of a “giant capillary” but one is by and 
large accepted as a capillary that is that is enlarged over four-fold normal diam-
eter (and often >ten-fold) (see Figure 3). A normal adult capillary is somewhere 
between 25-50um and therefore generally anything over 150um is considered 
pathologic. Enlarged capillaries are somewhere in between giant capillaries and 
normal. A useful clinical tip is to compare capillaries within the same patient to 
first establish the appearances and dimensions of their “normal” capillaries and use 
these to compare the enlarged capillaries against, if present. The presence of even a 
single giant capillary is very suggestive of an underlying connective tissue disease.
4.2 Avascular areas
Avascular areas or areas of capillary “drop-out” are regions where there are 
no capillaries and in the absence of local nailfold trauma are highly specific for 
Figure 2. 
The different techniques for performing nailfold capillaroscopy. (a) Widefield microscopy; (b) 
videocapillaroscopy; (c) dermoscopy (with a smartphone attachment).
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systemic sclerosis in particular (see Figure 4). Again, there is no internationally 
ratified definition but a working definition is a 1 mm region of the distal nailfold 
with no capillaries present. Another definition is the absence of two or more 
sequential capillary loops [14]. It can be difficult if there is not adequate visualisa-
tion of the nailfold for technical reasons or if it is difficult to get the appropriate 
depth of focus to bring all capillaries in to view. A simple tip is to compare within 
the same patients nailfolds to see if the usual density of capillaries (number within a 
defined width or area) is regionally varied.
4.3 Microhaemorrhages
These are evidenced by reddish-brown punctate lesions (haemosiderin stain-
ing) in the cuticle (see Figure 5). They are often associated with regional capillary 
architectural abnormalities (such as a giant capillary) and sometimes recurrent 
haemorrhage can be deduced from lesions “growing-out” along the cuticle over time.
4.4 Other abnormal capillary shapes
It is difficult to define “bushy”, “arborized” or excessively tortuous capillaries as 
these are qualitative judgements and experience dependent (see Figure 6). In addi-
tion, although cuticle hypertrophy is well recognised (although not that prevalent) 
there is no established definition for it and it is based upon a subjective assessment.
Figure 3. 
A single giant capillary, in this example associated with a microhaemorrhage in the distal cuticle.
Figure 4. 
Avascular areas, demonstrating areas of capillary “drop-out”. Note in the right-hand image the extensive 
associated microhaemorrhages and cuticle hypertrophy.
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Recently, the reliability of simple capillaroscopic definitions to describe the differ-
ent morphologies that can be seen in rheumatic diseases has been published and widely 
accepted [15]. Although there are a range of potential abnormalities which may seem 
relatively complex, there is actually very good intra- and inter-observer concordance in 
most studies and even only a short amount of training (for example an hour) can help 
complete novices make accurate assessments [16]. There has been encouraging results 
when capillaroscopy has been used in a primary care setting as well [17]. Two prospec-
tive studies in particular have elegantly demonstrated the prognostic significance of 
these abnormalities in patients with Raynaud’s phenomenon. Koenig et al. showed 
that giant capillaries and capillary loss strongly predict the evolution to a diagnosis 
of systemic sclerosis (then using the 1980 ACR criteria) and, when combined with a 
relevant positive autoantibody, had a positive predictive value of 79% and negative 
predictive value of 93% [18]. A second study, by Ingegnoli et al., found that the three 
capillary abnormalities that correlated with a later diagnosis of systemic sclerosis were 
giant capillaries, capillary density and microhaemorrhages [19].
5. Classification
There is no universally adopted consensus on exactly how the varying combina-
tion of above potential capillary abnormalities should be classified and this is an 
ongoing research priority. Classification criteria have many discrete purposes from 
diagnostic criteria and we will cover only a few illustrative examples as our intended 
focus is on the use of capillaroscopy in the clinical rather than research setting.
Figure 5. 
Nailfold microhaemorrhages.
Figure 6. 
Other abnormal capillary shapes. (a) A tortuous capillary; (b) elongated capillaries.
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5.1 Qualitative criteria
The first proposed classification criteria was that of Maricq et al. who classified 
patient’s nailfold capillaries as having either “normal” appearances, “non-specific” 
abnormalities or the “Scleroderma-Dermatomyositis (or SD-) pattern” [2, 5]. This 
latter category was defined by the presence of giant capillaries or avascular areas 
and could include the other capillary abnormalities described above. It is this 
pattern that has now been shown in numerous publications to help differentiate 
primary from secondary Raynaud’s syndrome and as the pattern present in around 
90% of systemic sclerosis patients, often very early in the course of their disease 
[20]. In essence, therefore, it is these features that are of primary clinical signifi-
cance as they strongly suggest an associated underlying connective-tissue disease. 
The “non-specific” group consists of individuals who have some definite capillary 
abnormalities (such as microhaemorrhages, enlarged or tortuous capillaries), but 
neither of the more specific features of giant capillaries or avascular areas. From a 
clinical perspective, the significance of an investigation with these findings should 
usually be interpreted as normal but it may have some suggestive relevance when 
considered in the context of a patient’s history, examination and other investiga-
tions as supportive of a scleroderma-spectrum disorder.
5.2 Semi-quantitative criteria
Because of the intrinsic issues with purely qualitative classification systems, 
especially when trying to compare or reproduce different study methodologies and 
research findings, there have been many efforts to develop a more structured and 
systematic approach into criteria. A Brazilian group developed the Maricq scoring 
system and incorporated a count of the total number of enlarged or giant capillaries 
as well as a measure of mean capillary density (capillaries per mm) [21]. Other early 
efforts at moving towards a more quantitative classification included those by the 
research group of Lee et al. [14]. More recently, the most widely adopted criteria is that 
of Cutolo et al. who described “early”, “active” and “late” categories (see Table 1) for 
individuals with definite capillary abnormal features [23]. Several studies have shown 
that the Cutolo criteria are associated with disease activity and severity. The “early” 
and “active” patterns are more common in limited SSc, whereas the “late” category is 
present more frequently in patients with diffuse SSc [24]. In the same study, the sever-
ity of organ involvement progressively increased across groups from “early” towards 
“late”. Other studies have reported the “late” pattern in older patients, in those with a 
longer disease duration, and in those with diffuse disease [15, 16]. Several studies have 
shown that the “late” pattern in particular predicts digital ulcers as well as more severe 
cutaneous, cardiac and pulmonary disease [24–27]. The initial Cutolo criteria was later 
simplified into a score ranging from 0 to 9, correlating to the average score for each of 
three variables in each of eight examined nailfolds [28].
Classification Description
Early Few giant capillaries, few haemorrhages and no capillary loss
Active Numerous giant capillaries and microhaemorrhages, mild capillary architecture 
disturbance and moderate capillary loss
Late Severe capillary loss with extensive avascular areas, disorganised capillaries and ramified 
capillaries.
Table 1. 
The Cutolo classification criteria [22].
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5.3 Quantitative criteria
Certain components of the capillaroscopic assessment are well suited to quan-
titative assessment. Capillary density (by convention the number of capillaries 
within a 1 mm region of the distal nailfold) is the best example of this, with any-
thing less than 6 per mm being pathologically abnormal. A quantitative method was 
employed in a recent multicentre study and involved counting all the microhaemor-
rhages, normal capillaries, enlarged capillaries, giant capillaries and other abnormal 
capillary shapes in the distal row within two 1 mm fields per finger [29]. The study 
concluded that the simple count of capillaries (i.e. capillary density) was sufficient 
to monitor the progression of scleroderma. Recently, some groups have used com-
puter technology to count capillaries and automate this quantitative process with 
good reproducibility and obvious potential advantages for future work [30, 31].  
Reduced capillary density has been associated with disease complications such as 
pulmonary hypertension, interstitial lung disease and digital ulcers. Many other 
capillary features have been measured and investigated including, for example, 
capillary length, angle and loop diameter, but the clinical relevance of these mea-
surements is not well established.
6. The established role
6.1 Distinguishing primary from secondary Raynaud’s syndrome
The first clearly established clinically relevant role for capillaroscopy was in the 
assessment of patients with Raynaud’s symptoms. Abnormal nailfold capillaroscopy 
is strongly predictive of an underlying connective tissue disease (synonymous with 
“secondary” Raynaud’s syndrome) and, conversely, normal nailfold capillaroscopy 
is reassuring that an underlying connective tissue disease is unlikely (“primary” 
Raynaud’s syndrome). The early work into the importance of nailfold capillary 
changes in identifying patients with secondary Raynaud’s syndrome is well sum-
marised in a systematic review from 1998, where abnormal capillaries had the high-
est odds ratio (OR) of any variable studied for progression to secondary diseases 
[32]. These findings have been replicated and enhanced in the prospective study of 
Koenig et al. over 3000 patient years, who found abnormal capillaries and systemic 
sclerosis-specific autoantibodies were both independent predictors of an underlying 
connective tissue disease [18]. Twenty-six percent of patients with capillary abnor-
malities at baseline (and 36% with a specific autoantibody) developed systemic 
sclerosis within follow up, which increased to 80% in subjects with both features. 
Conversely, only 1.8% of patients with neither present at baseline developed a con-
nective tissue disease during follow up. Similarly, a study from Pavlov-Dolijanovic 
et al. found 45% of their 3029 consecutive patients with Raynaud’s syndrome and 
abnormal NFC went on to develop a connective tissue disease. The OR for being 
diagnosed with systemic sclerosis in patients with abnormal NFC compared to those 
with Raynaud’s syndrome without capillary abnormalities was 183 (95% confidence 
intervals 97.9–271.5) [33].
6.2 Diagnosing systemic sclerosis
Abnormal capillaroscopy features are particularly useful in the diagnosis of 
systemic sclerosis (SSc) and are present in up to 90% of patients [34]. The work 
of Leroy and Medsger highlighted the importance of NFC in detecting early SSc 
in particular and much subsequent work has helped include capillaroscopy in the 
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most recent SSc classification criteria (see Table 2) [4, 35]. Abnormal capillaro-
scopic findings contribute 2 points towards the 9 points necessary to establish a 
diagnosis of SSc. If combined with Raynaud’s symptoms, a common indication 
for the investigation, it contributes a total of 4 points towards the diagnosis. The 
addition of capillaroscopy to the new criteria have helped improve their sensitiv-
ity for early and very early SSc which is an area of great interest to researchers 
seeking to find interventions and treatments to improve long-term outcomes 
[36, 37]. It could be argued on the basis of these criteria that access to NFC 
should be a pre-requisite for all clinicians and researchers evaluating patients 
with potential SSc.
6.3 A predictor of organ-specific manifestations in systemic sclerosis
There is an accumulating literature on the association between capillaroscopic 
findings and certain organ-specific complications of SSc. In general, the more 
severe morphological changes correlate with more severe disease [34, 38]. The 
converse is also true, where patients with less marked NFC abnormalities have less 
severe cutaneous and pulmonary involvement [39].
6.3.1 Digital ulcers
Digital ulcers (DU) are a visible representation of peripheral vasculopathy, 
occurring in up to 50% of patients at some point in their illness [40]. It stands 
to reason that capillaroscopic abnormalities would correlate with their presence 
and there has been considerable interest in applying capillaroscopy as a predictor 
of digital ulcers in systemic sclerosis. The association of capillary loss and digital 
ischaemia was first established almost a decade ago with work by Herrick et al. and 
Ennis et al. [37, 41]. The more recent video CAPillaroscopy (CAP) study showed the 
Item Sub-item Weight/score
Skin thickening of fingers of both hands extending 
proximal to the MCPs
– 9
Skin thickening (only count the higher score) Puffy fingers 2
Sclerodactyly 4
Finger tip lesions (only count the higher score) Digital tip ulcers 2
Finger tip pitting scars 3
Telangiectasia – 2
Abnormal nailfolds – 2
Pulmonary arterial hypertension and/or interstitial 
lung disease (maximum of 2)
Pulmonary arterial 
hypertension
2
Interstitial lung disease 2
Raynaud’s phenomenon – 2
SSc-related autoantibodies (maximum score is 3) Anti-Scl70 (anti-
topoisomerase I)
3
Anti-centromere
Anti-RNA polymerase III
Patients with a score of ≥9 are classified as having definite systemic sclerosis.
Table 2. 
The 2013 classification criteria for systemic sclerosis [4].
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mean number of capillaries in the dominant hand middle finger (per mm) was one 
of three predictors of DU (the two others being number of DUs at enrolment and 
critical digital ischaemia at enrolment) [29]. The “late” NFC pattern (see Table 1)  
has been shown in a prospective longitudinal study to be an independent predic-
tor for DU in patients both with and without a history of DUs [42]. NFC findings 
may help in future target high risk patients for vascular remodelling and protec-
tive strategies. Indeed, a prognostic tool, the capillaroscopic skin ulcer risk index 
(CSURI), has been developed and demonstrated to help predict ulcers in the 3 
months following assessment [43]. Another similar tool to predict digital trophic 
lesions intended for day-to-day clinical used based upon a simple capillary count 
has also been described [44].
6.3.2 Pulmonary hypertension
Pulmonary hypertension affects around 15% of patients with systemic sclerosis 
and despite advances in therapy still accounts for substantial morbidity and mortal-
ity [45]. Because of its relatively lower prevalence than other organ specific mani-
festations, it is more difficult to explore the role of NFC in predicting its presence 
or severity but some studies have already shown some intriguing results. In a recent 
Dutch cohort of over 200 patients, NFC changes were independently predictive of 
cardio-respiratory complications and, notably, all patients with pulmonary hyper-
tension had abnormal NFC [46]. The “late” pattern and reduced capillary density 
have both been associated with the presence and severity of pulmonary hyperten-
sion in SSc [47, 48].
6.3.3 Interstitial lung disease
Interstitial lung disease (ILD) is present in up to 80% of patients with systemic 
sclerosis and, although only around 25% develop progressive disease, this again 
contributes to substantial morbidity and mortality [35]. In a retrospective observa-
tional study an association was found between abnormal NFC and the presence of 
ILD [49]. Capillaroscopic abnormalities were associated with a mean 15% reduction 
in forced vital capacity and DLCO compared to participants with normal capil-
laroscopy findings. Multiple other studies have also found an association between 
abnormal capillaroscopy and the presence or severity of ILD [27, 34, 46].
6.3.4 Mortality
Abnormal NFC has been associated with an increased mortality. A study 
of almost 3000 patients with Raynaud’s symptoms but without an established 
diagnosis of a CTD was conducted for a mean of 9.3 years. An increased all-cause 
mortality rate was found for females (HR 1.10; 1.07–1.77) but this association was 
interestingly not found for males, although the substantially fewer males with 
Raynaud’s syndrome and relatively short follow up for this outcome measure may 
have impacted [50]. A more recent study also found an association between capil-
lary loss and mortality, although this did not remain significant after multi-variant 
adjustment [51].
7. The emerging role
There has never been more activity and interest in capillaroscopy and its appli-
cations are only likely to expand over time. Although its role in the diagnosis of SSc 
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is well established, it is emerging as having a role in a variety of other CTDs such as 
the idiopathic inflammatory myopathies (IIM) and mixed connective tissue disease 
(MCTD). Even within SSc there is much ongoing work into further understanding 
the potential role for capillaroscopy in more accurately screening and monitoring 
for disease complications and as a putative biomarker. Others are evaluating the 
potential role of capillaroscopy in monitoring the efficacy of new therapies and as a 
trial outcome measure. Finally, it is likely that capillaroscopy can be combined with 
complementary technologies or investigations to better serve the need for progress 
in the understanding and management of CTDs.
7.1 Use in other connective tissue diseases
7.1.1 Idiopathic inflammatory myopathies
Implicit in Maricq’s initial qualitative classification of the “scleroderma-derma-
tomyositis” pattern was a recognition that dermatomyositis (DM) had similar nail-
fold capillary changes to SSc. This perhaps is not surprising given, like SSc, DM is a 
condition characterised by microvasculopathy and, along with other IIM subtypes 
such as the anti-synthetase syndrome and overlap myositis, it shares many clinical 
manifestations such as Raynaud’s syndrome, myositis and cutaneous involvement 
[52]. NFC has not been as thoroughly evaluated in this patient group as in SSc but 
there are some interesting findings. An Italian study of 52 patients with IIM found 
nailfold changes were significantly more common in patients with DM versus poly-
myositis (PM) and that disease duration seemed to have an impact on the features, 
as patients with longer disease duration had less of the “late” features [53]. This may 
seem counter-intuitive and the opposite of the findings in SSc where there is a trend 
towards more “late” pattern changes with increasing disease duration, but the study 
was not controlled for the impact of treatment on the capillary features. In an earlier 
study from Spain, the combination of microhaemorrhages and capillary enlarge-
ment was found more frequently in patients with DM versus PM (OR 8.9)  
and overall in their cohort of 53 patients with IIM, found the prevalence of 
abnormal NFC to be 43% [54]. This study also found an association between NFC 
abnormalities and both disease activity and damage. There was a low incidence of 
capillary loss (in 20% of DM patients and 0% of PM patients) and the authors con-
cluded that the pathogenesis of the disease is therefore likely different from that of 
systemic sclerosis, where avascular areas are far more prominent. The authors also 
concluded that abnormal NFC contributed to an earlier diagnosis of IIM and likely 
marks out patients for a poorer prognosis. There is limited information on longi-
tudinal changes over time in patients with IIM but one study of quantitative capil-
laroscopy in these patients versus healthy controls found a progressive reduction in 
capillary density in patients with anti-Jo-1 positive anti-synthetase syndrome [55]. 
Another recent study has reported some relatively subtle longitudinal differences in 
the nailfolds of patients with IIM compared to SSc [56].
7.1.2 Mixed connective tissue disease
Many patients with MCTD, which again shares considerable clinical mani-
festation overlap with SSc, will have NFC abnormalities although this has not 
been studied in isolation [33]. The recent study by Markusse et al. found that the 
“early” pattern was associated with a positive anti-RNP antibody, a hint that, 
similar to NFC in the IIM, MCTD may have differing underlying microvascular 
pathophysiology with less avascular areas or capillary drop-out compared to 
patients with SSc [46].
Connective Tissue Disease - Current State of the Art
12
7.1.3 Systemic lupus erythematosus
In a recent systematic review, Cutolo et al. have helped summarise the limited 
existing literature of NFC in systemic lupus erythematosus (SLE) [57]. Although 
differences in the prevalence of capillary abnormalities in patients with SLE com-
pared to normal controls have been found (especially with increased capillary tortu-
osity, prominent venous plexus and elongated capillaries), these are usually subtle 
compared to the more marked findings in SSc and IIM. An increased NFC score did 
correlate with disease activity in the majority of the few studies that reported on 
this, especially with the frequency of Raynaud’s symptoms or digital gangrene.
7.2 Capillaroscopy as a putative biomarker
Although the role of NFC in diagnosis is well established, its role, if any, in 
established disease is less clear – could serial examinations be used to screen for 
complications in much the same way as an annual echocardiogram and pulmonary 
function tests would do? Prospective longitudinal studies are required to properly 
address this question, and some are already completed or underway. A recent study 
by Avouac et al. followed patients prospectively over three years and found that 
changes in NFC over time (in particular a loss of capillary density to <4 per mm), 
which occurred in almost half of patients, was a strong marker of organ progression 
[58]. As mentioned above numerous studies have linked the “late” NFC pattern with 
SSc disease activity, digital ulcers, cutaneous, cardiac and pulmonary involvement, 
which suggests an evolution of NFC changes over time [24, 26, 27]. A study from 
Brazil looked at overall mortality within a group of patients with SSc and found an 
increased mortality in those with more marked capillary loss [59]. Longitudinal 
NFC assessments in patients with systemic sclerosis could become feasibly become 
a part of routine care [60]. The comprehensive review by Ingegnoli & Gualtierotti 
also summarises the literature to date on the association between abnormalities of 
NFC and other serum biomarkers such as endothelin-1 and VEGF, which offers 
an insight into a potential future where biomarkers could be combined to stratify 
patients and personalise management [9].
7.3 Nailfold capillaroscopy and therapeutics
Another area that is being researched intensively is in the arena of monitor-
ing effects of drugs on nailfold changes. If, as has been largely established, the 
structural microvascular changes in CTDs can associate with disease activity, it 
would also make sense that a successful treatment may reverse the microvascular 
changes. NFC could therefore be used as a measure of treatment efficacy or even 
a trial outcome measure. There have been reports of significant improvements 
in microangiopathy paralleling the substantial clinical improvement in patients 
after autologous haematopoeitic stem cell transplant (HSCT) for SSc as well as in 
a patient with anti-synthetase syndrome [61–63]. In one report (of two patients 
with SSc and MCTD respectively), progressive improvements in NFC were seen 
with the cyclophosphamide used for stem cell mobilisation and then the subsequent 
HSCT [63]. Despite the evidence that endothelin-1 inhibitors reduce the incidence 
of digital ulcer recurrence and Raynaud’s symptoms [64–66], two studies have 
failed to find significant changes in structural microvascular changes [67, 68]. 
However, the follow up of these studies was relatively short and it has been argued 
that the true impact of endothelin-1 antagonists on structural microvascular change 
may take longer to establish. Similarly, intravenous prostanoid therapy was not 
associated with NFC improvements at 12 months despite a statistically significant 
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improvement in Raynaud’s symptoms [69]. Some researchers are already postulat-
ing that making an early diagnosis of SSc in patients with NFC abnormalities may 
allow for the early instigation of preventative therapies (e.g. endothelin-1 antago-
nists to prevent pulmonary hypertension, antifibrotic therapies to prevent ILD) and 
therefore help change the natural history of the disease [70].
7.4 Combining NFC with other technologies
As technology rapidly advances there may become available a variety of novel 
techniques that allow for image acquisition. Inexpensive USB microscopes are 
already available as are accessory equipment allowing the digital camera of a smart 
phone to take diagnostically useful images [11]. Technology could also be harnessed 
to allow for quicker and more reproducible image assessment, as in the case of 
the recent publication of automated capillary counting [30]. NFC is an excellent 
measure of structural microvascular changes in disease, but the role and assessment 
of functional changes may also add clinically useful information. Thermography, 
where the skin surface temperature is measured using thermal cameras, is already 
well established at some expert centres [20]. The equipment is relatively expensive 
and requires regular calibration but technology is advancing and soon thermal 
cameras may be available as smartphone attachments. Several studies have shown 
thermography to be able to differentiate between healthy controls and primary 
Raynaud’s and between primary Raynaud’s and Raynaud’s secondary to systemic 
sclerosis based upon an abnormal pattern (a persistent “distal-dorsal difference”) 
of rewarming [71, 72]. Although thermography as a stand-alone test has some 
utility, further work may help establish that, in time, assessments of patients with 
potential CTD may include both a structural assessment in the form of NFC and a 
functional assessment. Developing a standardised protocol for thermography with 
a plan to validate the protocol to assist ongoing research in thermography is already 
underway [39]. Another novel strategy for functional perfusion assessment is to 
use Laser technology. Techniques such as laser Doppler flowmetry and laser speckle 
contrast analysis (LASCA) have shown good reliability in patients with SSc [73–77]. 
Advances are occurring in parallel with advances in other non-invasive imaging 
techniques such as optical coherence tomography and photoacoustic imaging  
which allow the opportunity to view the skin and cutaneous vessels in three  
dimensions [20].
8. Future directions
Despite the great progress made by research into NFC over the last 50 years there 
is much work that is still required to be done. There is a great need for a widely-
accepted consensus classification criteria. Work needs to continue to improve 
awareness of and access to the investigation which will be aided by more convenient 
and cheaper technologies. Prospective longitudinal studies will allow for a better 
understanding of certain nailfold capillary abnormalities and their link with organ-
specific complications, disease severity, disease activity and hopefully, in time, the 
efficacy of certain treatments. Further work will also target other related CTDs.
9. Conclusions
Nailfold capillaroscopy is a simple, non-invasive, and non-expensive investiga-
tion with established roles in the diagnosis of scleroderma-spectrum disorders as 
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well as being linked to the presence and severity of a variety of serious organ-spe-
cific manifestations which account for substantial morbidity and mortality. Access 
to the investigation is likely to increase as technology makes equipment more user 
friendly, reproducible and inexpensive. Demand for the investigation is similarly 
going to increase substantially as it has been included in recent classification criteria 
for SSc and the potential clinical applications are only increasing in a wide range 
of conditions characterised by microangiopathy. Because microvascular change is 
often present very early in the clinical disease course, nailfold capillaroscopy may 
be a tool to identify a “window of opportunity”, in conditions which to date have 
proven largely refractory to the therapies employed with much greater success in 
other rheumatic and autoimmune disease. It may usher in a new era of preventative 
rather than reactionary therapy and may become a part of disease management 
decisions, perhaps in a similar way to the use of clinical ultrasound in patients 
with rheumatoid arthritis. It is of relevance to all clinicians seeing patients with 
suspected connective tissue diseases to stay abreast of the progress being made in 
nailfold capillaroscopy and the related investigations.
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